1. Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
   Sara S. Rinne et al, 2020, International Journal of Molecular Sciences CrossRef
2. Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
   Charles Dahlsson Leitao et al, 2020, Pharmaceutics CrossRef
3. Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26
   Bogdan Mitran et al, 2019, Scientific Reports CrossRef
4. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers
   Charles Dahlsson Leitao et al, 2019, International Journal of Molecular Sciences CrossRef
5. Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules
   Sara S. Rinne et al, 2019, Scientific Reports CrossRef
6. Affibody Molecules as Targeting Vectors for PET Imaging
   Vladimir Tolmachev et al, 2020, Cancers CrossRef
7. Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
   Sara S. Rinne et al, 2019, Scientific Reports CrossRef
8. Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
   Maria Rosestedt et al, 2019, Scientific Reports CrossRef
9. PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
   Sara S. Rinne et al, 2021, International Journal of Molecular Sciences CrossRef
10. Production, Purification, and Applications of a Potential Theranostic Pair: Cobalt-55 and Cobalt-58m
    Kendall E. Barrett et al, 2021, Diagnostics CrossRef